Can a patient-tailored treatment approach for Graves' disease reduce mortality?
- PMID: 30827828
- DOI: 10.1016/S2213-8587(19)30057-9
Can a patient-tailored treatment approach for Graves' disease reduce mortality?
Comment on
-
Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.Lancet Diabetes Endocrinol. 2019 Apr;7(4):278-287. doi: 10.1016/S2213-8587(19)30059-2. Epub 2019 Feb 28. Lancet Diabetes Endocrinol. 2019. PMID: 30827829
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
